Literature DB >> 24668936

Hypoxia, metabolism, and growth factor signaling in head and neck squamous cell carcinoma: correlation between primary and xenograft tumors.

Hanneke Stegeman1, Saskia E Rademakers, Paul N Span, Robert P Takes, Albert J van der Kogel, Johannes H A M Kaanders, Johan Bussink.   

Abstract

BACKGROUND: Hypoxia, metabolism, and growth factor signaling are important prognostic features in most solid tumors. The purpose of this study was to determine whether head and neck squamous cell carcinoma (HNSCC) xenografts show similar biological and molecular characteristics as the primary tumor they originate from.
METHODS: Eighteen HNSCC primary tumor-xenograft pairs were immunofluorescently stained for pimonidazole (hypoxia), carbonic anhydrase IX (CAIX), glucose transporter-1 (GLUT-1), monocarboxylate transporter-1 (MCT-1), monocarboxylate transporter-4 (MCT-4), epidermal growth factor receptor (EGFR), and phosphorylated protein kinase B (pAKT).
RESULTS: Although no correlation was found for the amount of hypoxia, significant correlations between primary tumors and xenografts were observed for both the percentage of cells positive for expression and the hypoxia-related expression pattern of CAIX, GLUT-1, and MCT-1. For EGFR and MCT-4, the intensity of expression was correlated. No correlation was observed for pAKT.
CONCLUSION: Xenografts did not always resemble the primary tumor they originate from, but the xenografts did represent the variability in expression levels and patterns observed in the primary tumors.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  growth factor signaling; head and neck squamous cell carcinoma; hypoxia; metabolism; xenografts

Mesh:

Substances:

Year:  2013        PMID: 24668936     DOI: 10.1002/hed.23446

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  Prognostic significance of monocarboxylate transporter expression in oral cavity tumors.

Authors:  Susana Simões-Sousa; Sara Granja; Céline Pinheiro; Daniela Fernandes; Adhemar Longatto-Filho; Ana Carolina Laus; Cira Danielle Casado Alves; J M Suárez-Peñaranda; Mario Pérez-Sayáns; Andre Lopes Carvalho; Fernando C Schmitt; Abel García-García; Fatima Baltazar
Journal:  Cell Cycle       Date:  2016-05-27       Impact factor: 4.534

2.  Monocarboxylate Transporter 4 in Cancer-Associated Fibroblasts Is a Driver of Aggressiveness in Aerodigestive Tract Cancers.

Authors:  Marina Domingo-Vidal; Diana Whitaker-Menezes; Mehri Mollaee; Zhao Lin; Madalina Tuluc; Nancy Philp; Jennifer M Johnson; Tingting Zhan; Joseph Curry; Ubaldo Martinez-Outschoorn
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

3.  Poor outcome in hypoxic endometrial carcinoma is related to vascular density.

Authors:  Casper Reijnen; Willem Jan van Weelden; Martijn S J P Arts; Johan P Peters; Paul F Rijken; Koen van de Vijver; Maria Santacana; Peter Bronsert; Johan Bulten; Marc Hirschfeld; Eva Colas; Antonio Gil-Moreno; Armando Reques; Gemma Mancebo; Camilla Krakstad; Jone Trovik; Ingfrid S Haldorsen; Jutta Huvila; Martin Koskas; Vit Weinberger; Lubos Minar; Eva Jandakova; Marc P L M Snijders; Saskia van den Berg-van Erp; Heidi V N Küsters-Vandevelde; Xavier Matias-Guiu; Frederic Amant; Leon F A G Massuger; Johan Bussink; Johanna M A Pijnenborg
Journal:  Br J Cancer       Date:  2019-04-23       Impact factor: 7.640

Review 4.  Patient-Derived Xenograft and Organoid Models for Precision Medicine Targeting of the Tumour Microenvironment in Head and Neck Cancer.

Authors:  Tet Woo Lee; Amy Lai; Julia K Harms; Dean C Singleton; Benjamin D Dickson; Andrew M J Macann; Michael P Hay; Stephen M F Jamieson
Journal:  Cancers (Basel)       Date:  2020-12-12       Impact factor: 6.639

5.  Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors.

Authors:  Bianca A W Hoeben; Maud H W Starmans; Ralph T H Leijenaar; Ludwig J Dubois; Albert J van der Kogel; Johannes H A M Kaanders; Paul C Boutros; Philippe Lambin; Johan Bussink
Journal:  BMC Cancer       Date:  2014-02-26       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.